| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |